Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Nicastrin ELISA Kit (AC3548)
Cat.#: ASET-2137
Specifications
Description Human Nicastrin ELISA Kit allows for the in vitro quantitative determination of human Nicastrin concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1494 Human Glutamate Receptor 1 (AMPA subtype) ELISA Kit (AC2905) Quantitative inquiry ASET-1769 Rat GRK2 ELISA Kit (AC3180) Quantitative inquiry ASET-1683 Human NOX3 ELISA Kit (AC3094) Quantitative inquiry ASET-1976 Human VAT1 ELISA Kit (AC3387) Quantitative inquiry ASET-1649 Rat Syndecan-1 ELISA Kit (AC3060) Quantitative inquiry ASET-1444 Human SorCS1 ELISA Kit (AC2855) Quantitative inquiry ASET-1161 Human SYNGR4 ELISA Kit (AC2572) Quantitative inquiry ASET-1585 Rat iNOS ELISA Kit (AC2996) Quantitative inquiry ASET-2054 Mouse Nestin ELISA Kit (AC3465) Quantitative inquiry ASET-1955 Rat Cannabinoid Receptor I ELISA Kit (AC3366) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket